SCHEMBL16120090

SCHEMBL16120090

CCCn1c2ccccc2c2cccnc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.56
▸ POLB P06746 4/20 0.56
▸ LMNA P02545 3/20 0.56
▸ USP2 O75604 2/20 0.56
▸ TSHR P16473 2/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ CASP1 P29466 1/20 0.56
▸ CASP7 P55210 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ HDAC3 O15379 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC2 Q92769 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ PGR P06401 2/20 0.47
▸ RORA P35398 1/20 0.47
▸ RORC P51449 1/20 0.47
▸ RORB Q92753 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29038434 0.90 RORA (0.60) MAPTPOLBLMNAUSP2TSHR
SCHEMBL29038442 0.88 PGR (0.54) MAPTLMNAPGRRORARORC
SCHEMBL17461858 0.88 PDE4A (0.51) MAPTPOLBLMNAUSP2TSHR
SCHEMBL19009217 0.86 PTGER4 (0.57) MAPTLMNAUSP2TSHRMAPK1
SCHEMBL17461857 0.84 MAOA (0.50) MAPTPOLBLMNAUSP2TSHR
SCHEMBL24822481 0.83 HTR6 (0.51) MAPTPOLBLMNAUSP2TSHR
SCHEMBL24822434 0.83 HDAC3 (0.47) MAPTPOLBTSHRHDAC3HDAC1
SCHEMBL12110553 0.80 MAPT (0.56) MAPTPOLBLMNAUSP2TSHR
SCHEMBL17274752 0.80 MAPT (0.64) MAPTPOLBLMNAUSP2TSHR
SCHEMBL153959 0.80 ALDH1A1 (0.62) MAPTPOLBLMNAUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217567-B Hydrocarbyl-substituted alpha-carboline analogue or pharmaceutically acceptable salt thereof, pharmaceutical composition thereof, preparation method and application thereof 潍坊医学院 2024-06-14 — — CN disclosed
CN-116217567-A Hydrocarbyl-substituted alpha-carboline analogue or pharmaceutically acceptable salt thereof, pharmaceutical composition thereof, preparation method and application thereof 潍坊医学院 2023-06-06 — — CN disclosed
WO-2014153043-A1 COMPOUNDS AND METHODS FOR TREATING CANCERS HEALTH RESEARCH, INC. (US) 2014-09-25 — — WO disclosed
Send feedback